Travis Whitfill

Travis Whitfill

Company: Azitra Inc.

Job title: Chief Operating Officer


Outlining ATR-12 for the Treatment of Netherton Syndrome 3:00 pm

Outlining ATR-12 as a novel genetically modified strain of S. epidermidis to be auxotrophic and secrete an active fragment of the full-length LEKTI protein for the treatment of Netherton syndrome (NS) patients, a rare autosomal recessive disease of the skin Revealing studies that show ATR-12 secretes sufficient LEKTI to reverse the underlying causes of NS…Read more

day: Conference Day Two Track B PM 1

Panel Discussion: Getting into the Clinic 12:30 pm

Navigating challenges in entering the clinic Patient stratification, interindividual variation & more Attracting and working with investorsRead more

day: Conference Day Two Track B AM 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.